Search

everythinglearnresearchcommunity

for

Search:↓

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

NDRG1 protein helps infantile hemangioma, a common infant tumor, to grow, and its mismanagement by FOXO1 protein plays a big role in causing the tumor.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.

The study found that aging hair follicle stem cells change behavior, leading to hair loss, but drugs targeting these cells may help restore hair growth.

Metabolic syndrome may increase the risk of small cell lung cancer.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

A 69-year-old smoker was wrongly diagnosed with lung cancer but actually had a rare lymphatic system disorder.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

Ovarian hemangioma is a rare, benign tumor that can be treated effectively with surgical removal.

PRP injections for hair loss may cause scalp nodules that can persist but often regress on their own.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

This enzyme helps metabolize fatty acids and isoleucine, and could be key in treating neurological diseases and certain cancers.

Ectopic adrenal rests can cause androgen excess after adrenalectomy and may need targeted surgery.

A new DSG4 gene mutation causes hair defects in a young girl.

The OVOL1-OVOL2 axis is important for hair follicle differentiation and can help diagnose certain hair-related tumors.

Elevated luteinizing hormone contributes to female-pattern hair loss, and blocking certain channels may help prevent it.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Bone marrow and hair follicle cells help form skin tumors, suggesting new treatment targets.

Certain genetic changes in the LSS gene cause a rare skin and hair condition.

Surgery and antifungal medication are effective for treating Merkel cell carcinoma with fungal infection.

ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.

A woman's cyclic Cushing syndrome was caused by a tumor in her adrenal gland that produced ACTH.

The early genes of a specific virus can cause abnormal skin cell growth and hair follicle changes.

A boy with a new NR5A1 gene mutation has a sex development disorder without affecting his adrenal glands.

A dog with a pituitary tumor developed tertiary hypothyroidism, improved with treatment, but was later euthanized due to neurological issues.

The cyst had unusual keratin spherules and resembled bone marrow.